Platelet Activating Factor-Induced Ceramide Micro-Domains Drive Endothelial NOS Activation and Contribute to Barrier Dysfunction

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Predescu, Sanda ^a   Knezevic, Ivana ^a   Bardita, Cristina ^a   Neamu, Radu Florin ^b   Brovcovych, Viktor ^c   Predescu, Dan ^a  

^a RUSH UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SPHINGOMYELIN PHOSPHODIESTERASE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FLUORESCENCE MICROSCOPY; IMMUNOGOLD LABELING; LUNG ENDOTHELIUM; MALE; MOUSE; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; CAPILLARY PERMEABILITY; CELL MEMBRANE; CERAMIDES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84884694454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075846     Document Type: Article

References (69)

1. Chignard M, Le Couedic JP, Tence M, Vargaftig BB, Benveniste J, (1979) The role of platelet-activating factor in platelet aggregation. Nature 279: 799-800. doi:10.1038/279799a0. PubMed: 377104.
2. Benveniste J, (1989) PAF-acether (platelet-activating factor). Adv Prostaglandin Thromboxane Leukot Res 19: 355-358. PubMed: 2526498.
3. Camussi G, Bussolino F, Tetta C, Piacibello W, Aglietta M, (1983) Biosynthesis and release of platelet-activating factor from human monocytes. Int Arch Allergy Appl Immunol 70: 245-251. doi:10.1159/000233331. PubMed: 6826235.
4. Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, et al. (1983) The release of platelet-activating factor from human endothelial cells in culture. J Immunol 131: 2397-2403. PubMed: 6415166.
5. Prescott SM, Zimmerman GA, McIntyre TM, (1984) Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A 81: 3534-3538. doi:10.1073/pnas.81.11.3534. PubMed: 6587368.
6. Sirois MG, Edelman ER, (1997) VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol 272: H2746-H2756. PubMed: 9227554.
7. Björk J, Smedegård G, (1983) Acute microvascular effects of PAF-acether, as studied by intravital microscopy. Eur J Pharmacol 96: 87-94. doi:10.1016/0014-2999(83)90532-0. PubMed: 6662199.
8. Humphrey DM, McManus LM, Hanahan DJ, Pinckard RN, (1984) Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab Invest 50: 16-25. PubMed: 6694349.
9. Predescu D, Ihida K, Predescu S, Palade GE, (1996) The vascular distribution of the platelet-activating factor receptor. Eur J Cell Biol 69: 86-98. PubMed: 8825027.
10. Knezevic II, Predescu SA, Neamu RF, Gorovoy MS, Knezevic NM, et al. (2009) Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J Biol Chem 284: 5381-5394. PubMed: 19095647.
11. Marrache AM, Gobeil F Jr., Bernier SG, Stankova J, Rola-Pleszczynski M, et al. (2002) Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J Immunol 169: 474-481. PubMed: 12444157.
12. Bussolino F, Silvagno F, Garbarino G, Costamagna C, Sanavio F, et al. (1994) Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. J Biol Chem 269: 2877-2886. PubMed: 7507929.
13. Axelrad TW, Deo DD, Ottino P, Van Kirk J, Bazan NG, et al. (2004) Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J 18: 568-570. PubMed: 14715700.
14. Göggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, et al. (2004) PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 10: 155-160. doi:10.1038/nm977. PubMed: 14704790.
15. Ihida K, Predescu D, Czekay RP, Palade GE, (1999) Platelet activating factor receptor (PAF-R) is found in a large endosomal compartment in human umbilical vein endothelial cells. J Cell Sci 112(3):: 285-295.
16. Brock TA, Gimbrone MA Jr., (1986) Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells. Am J Physiol 250: H1086-H1092. PubMed: 3717361.
17. Grigorian GY, Ryan US, (1987) Platelet-activating factor effects on bovine pulmonary artery endothelial cells. Circ Res 61: 389-395. doi:10.1161/01.RES.61.3.389. PubMed: 3040294.
18. Durán WN, Seyama A, Yoshimura K, González DR, Jara PI, et al. (2000) Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. Microvasc Res 60: 104-111. doi:10.1006/mvre.2000.2250. PubMed: 10964584.
19. Walford G, Loscalzo J, (2003) Nitric oxide in vascular biology. J Thromb Haemost 1: 2112-2118. doi:10.1046/j.1538-7836.2003.00345.x. PubMed: 14521592.
20. Jacobson J, (2002) Nitric oxide: platelet protectant properties during cardiopulmonary bypass/ECMO. J Extra Corpor Technol 34: 144-147. PubMed: 12139124.
21. Hickey MJ, Kubes P, (1997) Role of nitric oxide in regulation of leucocyte-endothelial cell interactions. Exp Physiol 82: 339-348. PubMed: 9129948.
22. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB, (2005) Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 289: L371-L381. doi:10.1152/ajplung.00175.2004. PubMed: 16093363.
23. Boo YC, Kim HJ, Song H, Fulton D, Sessa W, et al. (2006) Coordinated regulation of endothelial nitric oxide synthase activity by phosphorylation and subcellular localization. Free Radic Biol Med 41: 144-153. doi:10.1016/j.freeradbiomed.2006.03.024. PubMed: 16781462.
24. Mount PF, Kemp BE, Power DA, (2007) Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42: 271-279. doi:10.1016/j.yjmcc.2006.05.023. PubMed: 16839566.
25. Fleming I, (2010) Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 459: 793-806. doi:10.1007/s00424-009-0767-7. PubMed: 20012875.
26. Fulton D, Ruan L, Sood SG, Li C, Zhang Q, et al. (2008) Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation. Role ENOS Phosphor Tyr83. Circ Res 102: 497-504.
27. Harris MB, Ju H, Venema VJ, Liang H, Zou R, et al. (2001) Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 276: 16587-16591. doi:10.1074/jbc.M100229200. PubMed: 11340086.
28. Montagnani M, Chen H, Barr VA, Quon MJ, (2001) Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem 276: 30392-30398.
29. Durán WN, Breslin JW, Sánchez FA, (2010) The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res 87: 254-261. doi:10.1093/cvr/cvq139. PubMed: 20462865.
30. Liu J, García-Cardeña G, Sessa WC, (1996) Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35: 13277-13281. doi:10.1021/bi961720e. PubMed: 8873592.
31. Sánchez FA, Rana R, González FG, Iwahashi T, Durán RG, et al. (2011) Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. J Biol Chem 286: 30409-30414. doi:10.1074/jbc.M111.234294. PubMed: 21757745.
32. Gorodeski GI, (2000) NO increases permeability of cultured human cervical epithelia by cGMP-mediated increase in G-actin. Am J Physiol Cell Physiol 278: C942-C952. PubMed: 10794668.
33. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R, (1979) An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci U S A 76: 5674-5678. doi:10.1073/pnas.76.11.5674. PubMed: 293671.
34. Singla S, Predescu D, Bardita C, Wang M, Zhang J, et al. (2011) Pro-inflammatory endothelial cell dysfunction is associated with intersectin-1s down-regulation. Respir Res 12: 46. doi:10.1186/1465-9921-12-46. PubMed: 21486462.
35. Predescu D, Horvat R, Predescu S, Palade GE, (1994) Transcytosis in the continuous endothelium of the myocardial microvasculature is inhibited by N-ethylmaleimide. Proc Natl Acad Sci U S A 91: 3014-3018. doi:10.1073/pnas.91.8.3014. PubMed: 8159697.
36. Predescu SA, Predescu DN, Palade GE, (1997) Plasmalemmal vesicles function as transcytotic carriers for small proteins in the continuous endothelium. Am J Physiol 272: H937-H949. PubMed: 9124458.
37. Cooper JA, Del Vecchio PJ, Minnear FL, Burhop KE, Selig WM, et al. (1987) Measurement of albumin permeability across endothelial monolayers in vitro. J Appl Physiol 62: 1076-1083. PubMed: 3571065.
38. Predescu D, Predescu S, McQuistan T, Palade GE, (1998) Transcytosis of alpha1-acidic glycoprotein in the continuous microvascular endothelium. Proc Natl Acad Sci U S A 95: 6175-6180. doi:10.1073/pnas.95.11.6175. PubMed: 9600937.
39. Predescu SA, Predescu DN, Palade GE, (2001) Endothelial Transcytotic Machinery Involves Supramolecular Protein-LipidComplexes. Mol Biol Cell 12: 1019-1033. doi:10.1091/mbc.12.4.1019. PubMed: 11294904.
40. Predescu SA, Predescu DN, Shimizu K, Klein IK, Malik AB, (2005) Cholesterol-dependent syntaxin-4 and SNAP-23 clustering regulates caveolar fusion with the endothelial plasma membrane. J Biol Chem 280: 37130-37138. doi:10.1074/jbc.M505659200. PubMed: 16118213.
41. Lachmanovich E, Shvartsman DE, Malka Y, Botvin C, Henis YI, et al. (2003) Co-localization analysis of complex formation among membrane proteins by computerized fluorescence microscopy: application to immunofluorescence co-patching studies. J Microsc 212: 122-131. doi:10.1046/j.1365-2818.2003.01239.x. PubMed: 14629561.
42. Zhang J, Leiderman K, Pfeiffer JR, Wilson BS, Oliver JM, et al. (2006) Characterizing the topography of membrane receptors and signaling molecules from spatial patterns obtained using nanometer-scale electron-dense probes and electron microscopy. Micron 37: 14-34. doi:10.1016/j.micron.2005.03.014. PubMed: 16081296.
43. Stolz DB, Jacobson BS, (1992) Examination of transcellular membrane protein polarity of bovine aortic endothelial cells in vitro using the cationic colloidal silica microbead membrane-isolation procedure. J Cell Sci 103(1):: 39-51. PubMed: 1331135.
44. Brovkovych V, Stolarczyk E, Oman J, Tomboulian P, Malinski T, (1999) Direct electrochemical measurement of nitric oxide in vascular endothelium. J Pharm Biomed Anal 19: 135-143. doi:10.1016/S0731-7085(98)00090-9. PubMed: 10698575.
45. Kojima H, Sakurai K, Kikuchi K, Kawahara S, Kirino Y, et al. (1998) Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem Pharm Bull (Tokyo) 46: 373-375. doi:10.1248/cpb.46.373.
46. Korzeniowski M, Shakor AB, Makowska A, Drzewiecka A, Bielawska A, et al. (2007) Fc gamma RII activation induces cell surface ceramide production which participates in the assembly of the receptor signaling complex. Cell Physiol Biochem 20: 347-356. doi:10.1159/000107520. PubMed: 17762163.
47. Földes-Filep E, Braquet P, Filep J, (1987) Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. Biochem Biophys Res Commun 148: 1412-1417. doi:10.1016/S0006-291X(87)80289-9. PubMed: 2825685.
48. Andries LJ, Brutsaert DL, Sys SU, (1998) Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res 82: 195-203. doi:10.1161/01.RES.82.2.195. PubMed: 9468190.
49. Quest AF, Leyton L, Párraga M, (2004) Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol 82: 129-144. doi:10.1139/o03-071. PubMed: 15052333.
50. Kuhr F, Lowry J, Zhang Y, Brovkovych V, Skidgel RA, (2010) Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides 44: 145-154. doi:10.1016/j.npep.2009.12.004. PubMed: 20045558.
51. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM, (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419-445. doi:10.1146/annurev.biochem.69.1.419. PubMed: 10966465.
52. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, et al. (1987) Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol 139: 2439-2446. PubMed: 3116081.
53. Jagnandan D, Sessa WC, Fulton D, (2005) Intracellular location regulates calcium-calmodulin-dependent activation of organelle-restricted eNOS. Am J Physiol Cell Physiol 289: C1024-C1033. doi:10.1152/ajpcell.00162.2005. PubMed: 15917301.
54. Kuebler WM, Yang Y, Samapati R, Uhlig S, (2010) Vascular barrier regulation by PAF, ceramide, caveolae, and NO- an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem 26: 29-40. doi:10.1159/000315103. PubMed: 20502002.
55. Hall CN, Garthwaite J, (2009) What is the real physiological NO concentration in vivo? Nitric Oxide 21: 92-103. doi:10.1016/j.niox.2009.07.002. PubMed: 19602444.
56. Michel T, (1999) Targeting and translocation of endothelial nitric oxide synthase. Braz J Med Biol Res 32: 1361-1366. PubMed: 10559837.
57. Sakoda T, Hirata K, Kuroda R, Miki N, Suematsu M, et al. (1995) Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxide. Mol Cell Biochem 152: 143-148. doi:10.1007/BF01076076. PubMed: 8751160.
58. Sessa WC, Barber CM, Lynch KR, (1993) Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ Res 72: 921-924. doi:10.1161/01.RES.72.4.921. PubMed: 7680289.
59. Sot J, Bagatolli LA, Goñi FM, Alonso A, (2006) Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys J 90: 903-914. doi:10.1529/biophysj.105.067710. PubMed: 16284266.
60. Haberkant P, Schmitt O, Contreras FX, Thiele C, Hanada K, et al. (2008) Protein-sphingolipid interactions within cellular membranes. J Lipid Res 49: 251-262. doi:10.1194/jlr.D700023-JLR200. PubMed: 17906222.
61. Feron O, Michel JB, Sase K, Michel T, (1998) Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry 37: 193-200. doi:10.1021/bi972307p. PubMed: 9425039.
62. Dudzinski DM, Michel T, (2007) Life history of eNOS: partners and pathways. Cardiovasc Res 75: 247-260. doi:10.1016/j.cardiores.2007.03.023. PubMed: 17466957.
63. Govers R, Bevers L, de Bree P, Rabelink TJ, (2002) Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. Biochem J 361: 193-201. doi:10.1042/0264-6021:3610193. PubMed: 11772391.
64. Reiner M, Bloch W, Addicks K, (2001) Functional interaction of caveolin-1 and eNOS in myocardial capillary endothelium revealed by immunoelectron microscopy. J Histochem Cytochem 49: 1605-1610. doi:10.1177/002215540104901214. PubMed: 11724908.
65. Heijnen HF, Waaijenborg S, Crapo JD, Bowler RP, Akkerman JW, et al. (2004) Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production. J Histochem Cytochem 52: 1277-1285. doi:10.1369/jhc.4A6307.2004. PubMed: 15385574.
66. Bulotta S, Cerullo A, Barsacchi R, Palma CD, Rotiroti D, et al. (2006) Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells. Exp Cell Res 312: 877-889. doi:10.1016/j.yexcr.2005.12.014. PubMed: 16427620.
67. Poisson C, Rollin S, Véronneau S, Bousquet SM, Larrivée JF, et al. (2009) Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation. J Immunol 183: 2747-2757. doi:10.4049/jimmunol.0802651. PubMed: 19620302.
68. Yang Y, Yin J, Baumgartner W, Samapati R, Solymosi EA, et al. (2009) Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. Eur Respir J 36: 417-427. PubMed: 19926744.
69. Kurzchalia TV, Hartmann E, Dupree P, (1995) Guilty by insolubility--does a protein's detergent insolubility reflect a caveolar location? Trends Cell Biol 5: 187-189. doi:10.1016/S0962-8924(00)88990-4. PubMed: 14731445.